EUVIMEDEUVIMED entdecken
Crossref

State-level policies and receipt of CDC-informed opioid thresholds among commercially insured new chronic opioid users

Martin J Calabrese, Fadia T Shaya, Francis Palumbo, Mary Lynn McPherson, Ester Villalonga-Olives, Zafar Zafari, Ryan Mutter

Journal of Opioid Management · 2024

DOI: 10.5055/jom.0824 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Opioid Management, 2024. Verfasst von Martin J Calabrese und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Practice, Sciences, and Health Outcomes Research, University of Maryland Baltimore School of Pharmacy; Center for Medicare, Centers for…. Hauptthemen laut MEDLINE: Analgesics, Opioid, Opioid-Related Disorders, Centers for Disease Control and Prevention, U.S.. Die Arbeit nennt 61 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To evaluate the association of state-level policies on receipt of opioid regimens informed by Centers for Disease Control and Prevention (CDC) morphine milligram equivalent (MME)/day recommendations.

Design

A retrospective cohort study of new chronic opioid users (NCOUs).

Setting

Commercially insured plans across the United States using IQVIA PharMetrics® Plus for Academics database with new chronic use between January 2014 and March 2015.

Participants

NCOUs with ≥60-day coverage of opioids within a 90-day period with ≥30-day opioid-free period prior to the date of the first qualifying opioid prescription.

Interventions

State-level policies including Prescription Drug Monitoring Program (PDMP) robustness and cannabis policies involving the presence of medical dispensaries and state-wide decriminalization. Main outcome measures: NCOUs were placed in three-tiered risk-based average MME/day thresholds: low (>0 to

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Analgesics, OpioidOpioid-Related DisordersCenters for Disease Control and Prevention, U.S.HumansUnited StatesRetrospective StudiesMaleFemaleAdultMiddle AgedPrescription Drug Monitoring ProgramsHealth PolicyMedical MarijuanaYoung Adult

Substanzen

Analgesics, OpioidMedical Marijuana

Autor:innen und Institutionen

  • Department of Practice, Sciences, and Health Outcomes Research, University of Maryland Baltimore School of Pharmacy; Center for Medicare, Centers for Medicare & Medicaid Services, Baltimore, Maryland. ORCID: https://orc…
  • Department of Practice, Sciences, and Health Outcomes Research, University of Maryland Baltimore School of Pharmacy, Baltimore, Maryland.
  • Congressional Budget Office, Health Analysis Division, Washington, DC.

Zitieren

APA

Calabrese, M. J., Shaya, F. T., Palumbo, F., McPherson, M. L., Villalonga-Olives, E., Zafari, Z., & Mutter, R. (2024). State-level policies and receipt of CDC-informed opioid thresholds among commercially insured new chronic opioid users. Journal of Opioid Management. https://doi.org/10.5055/jom.0824

Vancouver

Calabrese MJ, Shaya FT, Palumbo F, McPherson ML, Villalonga-Olives E, Zafari Z, et al. State-level policies and receipt of CDC-informed opioid thresholds among commercially insured new chronic opioid users. Journal of Opioid Management. 2024. doi:10.5055/jom.0824

BibTeX
@article{Calabrese2024,
  author = {Calabrese, Martin J and Shaya, Fadia T and Palumbo, Francis and McPherson, Mary Lynn and Villalonga-Olives, Ester and Zafari, Zafar and Mutter, Ryan},
  title = {State-level policies and receipt of CDC-informed opioid thresholds among commercially insured new chronic opioid users},
  journal = {Journal of Opioid Management},
  year = {2024},
  doi = {10.5055/jom.0824}
}
Kostenlos starten →